InvestorsHub Logo
Followers 14
Posts 817
Boards Moderated 0
Alias Born 02/24/2010

Re: None

Tuesday, 06/07/2016 2:41:51 PM

Tuesday, June 07, 2016 2:41:51 PM

Post# of 403408
Best SA article I ever read! Finally someone noting that following the science and trial results is only half the battle and Cellceutix in my view is completely losing the other half in expertise and financing.

The company relies too much on moving forward with Aspire and their shelf registry. Now with 3 potential blockbuster how are you going to pay for it all? At this point simply announcing new trials like B-UP only exasperates their financial conditions or those investors that worry about such, down ~5 million on the last 10Q. The market has the stock locked in under $2 and the only current forward path is dilute, dilute at these prices.

I like Cellceutix management team but the only clinical trial experience they have is at this particular company and the road forward with the FDA does not get easier. They have been adding some experience in to the mix, Dr. Trust etc for Brilacidin phase 3 but they need to add across the board.

Getting an experienced partner with Brilacidin, Kevetrin or Prurisol is much needed at this point and none of these drugs should be off the negotiation table. Polymed failed with a great antibiotic drug a lot of arrogance and no funds!

I can see the forest for the trees and it not a matter of patience anymore. Just announcing great trial results is not enough -GET A PARTNER gain financing and experience..Cellceutix -GET OUT OF THE BOX you put yourself in!

IMO =-)


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News